Scott Lippman to Launch NCI’s PreCancer Genome Atlas
November 29, 2021
Scott Lippman, MD, will lead the PreCancer Genome Atlas, an NCI-sponsored effort to map premalignant lesions and how they evolve into invasive cancers.
Your search for “Cancer Research” returned 1388 results
Analyzing Copies of Genes Offers New Treatment Possibilities for Ovarian Cancer
February 15, 2017
…of Medicine and Moores Cancer Center researchers has developed a new tool to analyze an often overlooked aspect of cancer genetics — an alteration that results in the loss or gain in a copy of a gene. This change, known as somatic copy-number alterations, may be key to disease progression…
Tumor-Activated Protein Promotes Cancer Spread
May 13, 2013
Researchers at the University of California, San Diego School of Medicine and UC San Diego Moores Cancer Center report that cancers physically alter cells in the lymphatic system – a network of vessels that transports and stores immune cells throughout the body – to promote the spread of disease, a…
Researchers Produce First Comprehensive Genomic Map of Head and Neck Cancers
January 29, 2015
…that includes scores of researchers from across the country representing dozens of universities and medical institutions has produced the most comprehensive integrative analysis yet of head and neck squamous cell carcinomas (HNSCCs), a particularly malignant and deadly type of tumor that accounts for roughly 3 percent of all cancers in…
DNA Mutations Shed in Blood Predicts Response to Immunotherapy in Patients with Cancer
October 1, 2017
In a first-of-its-kind study, University of California San Diego School of Medicine researchers report that a blood sample, or liquid biopsy, can reveal which patients will respond to checkpoint inhibitor-based immunotherapies.
CAR-T Immunotherapies May Have a New Player
June 29, 2018
…to target and kill cancer cells. In a new study, researchers at University of California San Diego School of Medicine and University of Minnesota report that similarly modified natural killer (NK) cells derived from human induced pluripotent stem cells (iPSCs) also displayed heightened activity against a mouse model of ovarian…
Predictive Proteins: Elevated Levels Trigger Metastatic Progression of Cancer Cells
February 26, 2016
Researchers at University of California, San Diego School of Medicine and Moores Cancer Center, with colleagues in Spain and Germany, have unraveled how elevated levels of particular proteins in cancer cells trigger hyperactivity in other proteins, fueling the growth and spread of a variety of cancers.
New Biomarker Identifies Colon Cancer Patients Who May Benefit from Chemotherapy
January 20, 2016
…new computer science approach, researchers at University of California, San Diego School of Medicine, Columbia University and Stanford University discovered a distinctive molecular feature — a biomarker — that identified colon cancer patients who were most likely to remain disease-free up to five years after surgery. The biomarker, a protein…
Anti-Leukemia Drug May Also Work Against Ovarian Cancer
November 17, 2014
An antibody therapy already in clinical trials to treat chronic lymphocytic leukemia (CLL) may also prove effective against ovarian cancer – and likely other cancers as well, report researchers at the University of California, San Diego School of Medicine.
State’s Stem Cell Agency Awards $18.2 Million Grant for B Cell Cancer Clinical Trial
August 24, 2017
The Independent Citizens Oversight Committee of the California Institute for Regenerative Medicine (CIRM) today unanimously approved an $18.29 million grant to University of California San Diego School of Medicine researchers to fund a phase Ib/IIa clinical trial of a novel combination drug therapy for B-cell cancers.
